Associated Risks, Opportunities and Outcomes: Insights from a Long-Term High-Volume Center Using Extracorporeal Membrane Oxygenation as a Bridging Tool to Lung Transplantation
The Thoracic and Cardiovascular Surgeon · 01.01.2026 · 74 (S 01 S 01) · S1-S70
DOI: 10.1055/s-0046-1817291 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2026. Verfasst von S. Kruszona und 10 weiteren Autor:innen.
Abstract (Originalsprache)
All articles of this category (opens in new window)
Background
Extracorporeal membrane oxygenation (ECMO) as a bridging tool is a well-established treatment option for critically ill patients awaiting lung transplantation (LTx), though the risk of complications should not be underestimated. The current study analyzed a 13-year experience with ECMO-bridging among all transplant indications.
Methods
All patients undergoing LTx between January 2012 and August 2025 were included. Outcomes were compared between ECMO-bridged and nonbridged patients. Median follow-up was 60 [IQR: 24–104] months.
Results
Among the 1,492 patients transplanted during the study period, 100 patients (7%) required ECMO-bridging (venovenous ECMO, n = 67; veno-arterial ECMO, n = 33). Four venovenous ECMO patients (4%) were converted to veno-arterial ECMO during bridging time. The most frequent transplant indication among ECMO-bridged patients was idiopathic pulmonary fibrosis (28%), followed by cystic fibrosis (23%) and primary pulmonary hypertension (PPH, 22%). Eleven bridged patients (11%) underwent re-transplantation, of which 10 (91%) required venovenous ECMO. Across all transplant indications (bridged and nonbridged patients), PPH had the highest proportion of bridged patients (24%), followed by cystic fibrosis (10%). Median bridging time to LTx was 11 (7–26) days. Forty-two ECMO-bridged patients further required invasive mechanical ventilation. ECMO-bridging configuration was maintained in all patients during LTx. Excluding PPH patients, in whom postoperative prolonged ECMO is maintained by institutional protocol, ECMO-bridged patients required more often postoperative prolonged ECMO support (19% vs. 4%, p < 0.001). Overall, bridged patients showed a significantly higher incidence of primary graft dysfunction grade 3 72 hours posttransplant (18% vs. 3.9%, p < 0.001) as well as higher in-hospital mortality rates (12% vs. 3.4%, p < 0.001) compared to nonbridged patients. One-, 5-, and 8-year posttransplant outcomes showed reduced graft survival in bridged vs. nonbridged patients (81 vs. 92, 64 vs. 73, 55 vs. 61, p = 0.14) and reduced CLAD-free survival (88 vs. 98, 68 vs. 75, and 59 vs. 67%, p = 0.17), without any statistical significance, respectively.
Conclusion
Although ECMO implantation is a life-saving bridging tool until a suitable organ offer is available, early mortality after LTx remains high among bridged patients. This study shows that further Lung Allocation Score optimization is necessary to reduce ECMO-bridging rates, particularly in PPH patients. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Kruszona, S., Aburahma, K., Manna, D. D., Avsar, M., Bobylev, D., Schwerk, N., Köditz, H., Ruhparwar, A., Greer, M., Salman, J., & Ius, F. (2026). Associated Risks, Opportunities and Outcomes: Insights from a Long-Term High-Volume Center Using Extracorporeal Membrane Oxygenation as a Bridging Tool to Lung Transplantation. The Thoracic and Cardiovascular Surgeon, 74(S 01 S 01), S1-S70. https://doi.org/10.1055/s-0046-1817291
Vancouver
Kruszona S, Aburahma K, Manna DD, Avsar M, Bobylev D, Schwerk N, et al. Associated Risks, Opportunities and Outcomes: Insights from a Long-Term High-Volume Center Using Extracorporeal Membrane Oxygenation as a Bridging Tool to Lung Transplantation. The Thoracic and Cardiovascular Surgeon. 2026;74(S 01 S 01):S1-S70. doi:10.1055/s-0046-1817291
BibTeX
@article{Kruszona2026,
author = {Kruszona, S. and Aburahma, K. and Manna, D. De and Avsar, M. and Bobylev, D. and Schwerk, N. and Köditz, H. and Ruhparwar, A. and Greer, M. and Salman, J. and Ius, F.},
title = {Associated Risks, Opportunities and Outcomes: Insights from a Long-Term High-Volume Center Using Extracorporeal Membrane Oxygenation as a Bridging Tool to Lung Transplantation},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {S 01 S 01},
pages = {S1--S70},
doi = {10.1055/s-0046-1817291}
}
EUVIMED